CHICAGO, IL—Following bioprosthetic valve surgery, anticoagulation with edoxaban (Savaysa; Daiichi Sankyo) is as effective as ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing tecarfarin, a clinical-stage ... ongoing research and anticoagulation best practice guidelines." ...

According to NASS, the Clinical Guidelines were based on a strict analytical process which included a strength of the ...

Through participation in the Corporate Council, Cadrenal Therapeutics will collaborate with the AC Forum as it works to identify and address unmet clinical needs, share cutting-edge research ...

“Our findings do not support the guideline recommended ... start of DOACs (within 4 days) in clinical practice.” Werring pointed out that starting anticoagulation early also had important ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

A new study published in the journal of Molecular Psychiatry found that heparin medication was linked to a delayed diagnosis ...